Large-scale testing (Phase 3)Ended earlyNCT01820962
What this trial is testing
Concentrated Citrate Locking to Reduce the Incidence of CVC-related Complications in Hematological Patients
Who this might be right for
Hematological MalignanciesBacteremiaThrombosis
Maastricht University Medical Center 212